Global Point Of Care
Risk stratification for MI in the ED
using high-sensitivity point-of-care troponin
Summary
This webinar explores how hs-TnI testing is transforming emergency care for suspected acute coronary syndrome in Canada. This informative session will cover clinical applications, implementation challenges, and the impact on patient care.
Learning Objectives
- Discusses the use and impact of rapid risk assessment strategies for patients with suspected acute coronary syndrome in the ED
- Evaluates new point-of care (POC) high sensitivity (HS) troponin assays and the evidence for assay use
- Describes the benefits of use of HS assays – both lab and POC
- Discuss clinical applications and the collaboration between emergency medicine, cardiology and lab
- Discusses key elements required for successful implementation of HS POC assays in the ED
This event is sponsored by Abbott.
Author / SPEAKER
Prof. Louise Cullen
MBBS (Hon) FACEM FESC Phd
Emergency Physician, Clinician Reseacher
Prof. Louise Cullen is an emergency physician, clinical trialist and outcomes researcher in acute diseases and biomarkers based in Brisbane, Australia. She is enthusiastically involved in the translation of research by clinical redesign and innovation and has authored over 300 publications in peer-reviewed journals. Dr. Cullen has developed and validated several early rule-out pathways for acute myocardial infarction that are in widespread practice.
Titles of those appearing in the recording represent their roles at the time the webinar took place and may not reflect their current positions.
Who Should Watch
Emergency medicine, Emergency practiticioners, Emergency clinicians